Wed, April 10, 2024

Luke Sergott Maintained (TWST) at Buy with Decreased Target to $40 on, Apr 10th, 2024

Luke Sergott of Barclays, Maintained "Twist Bioscience Corporation" (TWST) at Buy with Decreased Target from $45 to $40 on, Apr 10th, 2024.

Luke has made no other calls on TWST in the last 4 months.



There are 2 other peers that have a rating on TWST. Out of the 2 peers that are also analyzing TWST, 0 agree with Luke's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Luke


  • Sung Ji Nam of "Scotiabank" Maintained at Buy with Increased Target to $43 on, Monday, February 5th, 2024
  • Matthew Sykes of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $45 on, Thursday, January 18th, 2024